| Johnson, J I; Decker, S; Zaharevitz, D et al. (2001) Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials. Br J Cancer 84:1424-31 |
| Mertins, S D; Myers, T G; Hollingshead, M et al. (2001) Screening for and identification of novel agents directed at renal cell carcinoma. Clin Cancer Res 7:620-33 |
| Marcantonio, D; Panasci, L C; Hollingshead, M G et al. (1997) 2-Chloroethyl-3-sarcosinamide-1-nitrosourea, a novel chloroethylnitrosourea analogue with enhanced antitumor activity against human glioma xenografts. Cancer Res 57:3895-8 |
